Zdrowie i gospodarka · 23/02/1998

FDA Publishes Guidance on Carcinogenicity Testing for Pharmaceuticals

The FDA is releasing a new guidance document, S1B Testing for Carcinogenicity of Pharmaceuticals, developed under the International Conference on Harmonisation, which outlines alternative methods for evaluating the potential carcinogenic effects of pharmaceuticals on humans, potentially reducing the need for lengthy rodent studies.